Christopher Angell

CADENCE: Evolutionary Fragment-Based Discovery of Novel ABL1, HER1,

Christopher Angell, Dianjun Chen

Record of the development of the deep learning pipeline CADENCE, capable of generating novel competitive kinase inhibitors from amino acid sequence. CADENCE was trained on the Davis dataset of kinase inhibitors and binding scores, creating a binding affinity prediction model. Thi…Read more